Suppr超能文献

异基因 BK 病毒特异性 T 细胞治疗进行性多灶性白质脑病。

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

机构信息

From the Departments of Stem Cell Transplantation and Cellular Therapy (M.M., A.O., D.M., S.A., I.K., L.L., R.C., E.J.S., K.R.), Infectious Diseases (V.M.), Neuro-Oncology (S.T.), Diagnostic Radiology (T.L.C.), and Leukemia (A.F.), M.D. Anderson Cancer Center, Houston.

出版信息

N Engl J Med. 2018 Oct 11;379(15):1443-1451. doi: 10.1056/NEJMoa1801540.

Abstract

JC virus, the cause of progressive multifocal leukoencephalopathy (PML), and the BK virus are genetically similar and share sequence homology in immunogenic proteins. We treated three immunosuppressed patients with PML with ex vivo-expanded, partially HLA-matched, third-party-produced, cryopreserved BK virus-specific T cells. The immunosuppression in these patients was due to the conditioning regimen for cord-blood transplantation in one patient, a myeloproliferative neoplasm treated with ruxolitinib in another, and acquired immunodeficiency syndrome in the third. After T-cell infusion in two of the patients, alleviation of the clinical signs and imaging features of PML was seen and JC virus in the cerebrospinal fluid (CSF) cleared. The other patient had a reduction in JC viral load and stabilization of symptoms that persisted until her death 8 months after the first infusion. Two of the patients had immune reconstitution syndrome. Donor-derived T cells were detected in the CSF after infusion. (Funded by the M.D. Anderson Cancer Center Moon Shots Program and the National Institutes of Health; ClinicalTrials.gov number, NCT02479698 .).

摘要

JC 病毒是进行性多灶性白质脑病(PML)的病因,与 BK 病毒在遗传上相似,并在免疫原性蛋白中具有序列同源性。我们用体外扩增的、部分 HLA 匹配的、第三方生产的、冷冻保存的 BK 病毒特异性 T 细胞治疗了 3 例 PML 免疫抑制患者。这些患者的免疫抑制是由于一名患者接受了脐带血移植的预处理方案,另一名患者接受了鲁索利替尼治疗骨髓增生性肿瘤,还有一名患者患有获得性免疫缺陷综合征。在两名患者中输注 T 细胞后,PML 的临床症状和影像学特征得到缓解,脑脊液中的 JC 病毒清除。另一名患者的 JC 病毒载量减少,症状稳定,直到第一次输注后 8 个月死亡。两名患者出现免疫重建综合征。输注后在脑脊液中检测到供体来源的 T 细胞。(由 MD 安德森癌症中心 Moon Shots 计划和美国国立卫生研究院资助;临床试验.gov 编号,NCT02479698)。

相似文献

1
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
N Engl J Med. 2018 Oct 11;379(15):1443-1451. doi: 10.1056/NEJMoa1801540.
3
Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy.
Neurol Neuroimmunol Neuroinflamm. 2021 May 17;8(4). doi: 10.1212/NXI.0000000000001020. Print 2021 Jul.
4
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10.
6
Successful BK virus-specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy.
Am J Transplant. 2024 Sep;24(9):1698-1702. doi: 10.1016/j.ajt.2024.05.003. Epub 2024 May 9.
7
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Transplant Cell Ther. 2022 Feb;28(2):116.e1-116.e7. doi: 10.1016/j.jtct.2021.11.005. Epub 2021 Nov 14.
10
Combined Treatment With Pembrolizumab and Allogenic BK Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Case Report.
Neurol Neuroimmunol Neuroinflamm. 2021 Jul 20;8(5). doi: 10.1212/NXI.0000000000001042. Print 2021 Jul.

引用本文的文献

1
identification of the specificities of recurrent human T cell receptors.
bioRxiv. 2025 Aug 4:2025.08.03.668342. doi: 10.1101/2025.08.03.668342.
3
Natalizumab-associated progressive multifocal leukoencephalopathy.
Front Neurol. 2025 Jun 20;16:1575653. doi: 10.3389/fneur.2025.1575653. eCollection 2025.
5
Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation.
Viruses. 2025 Mar 12;17(3):403. doi: 10.3390/v17030403.
6
Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.
Transfus Med Hemother. 2024 Sep 25;52(1):5-26. doi: 10.1159/000540961. eCollection 2025 Feb.
8
Identifying CNS infections in transplantation and immunomodulatory therapy.
Ther Adv Infect Dis. 2024 Nov 9;11:20499361241298456. doi: 10.1177/20499361241298456. eCollection 2024 Jan-Dec.
9
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.
JAMA Neurol. 2024 Oct 7;81(11):1187-98. doi: 10.1001/jamaneurol.2024.3324.
10
Therapeutic advances in neuroinfectious diseases.
Ther Adv Infect Dis. 2024 Sep 20;11:20499361241274246. doi: 10.1177/20499361241274246. eCollection 2024 Jan-Dec.

本文引用的文献

2
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
Neurology. 2017 Mar 21;88(12):1197-1205. doi: 10.1212/WNL.0000000000003739. Epub 2017 Feb 22.
3
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Ther Adv Neurol Disord. 2015 Nov;8(6):255-73. doi: 10.1177/1756285615602832.
4
Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
Clin Infect Dis. 2014 Dec 1;59(11):1588-92. doi: 10.1093/cid/ciu682. Epub 2014 Sep 11.
5
Treatment of progressive multifocal leukoencephalopathy with interleukin 7.
JAMA Neurol. 2014 Aug;71(8):1030-5. doi: 10.1001/jamaneurol.2014.825.
7
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.
Neurology. 2013 Apr 9;80(15):1430-8. doi: 10.1212/WNL.0b013e31828c2fa1.
9
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
Bone Marrow Transplant. 2011 Jul;46(7):987-92. doi: 10.1038/bmt.2010.221. Epub 2010 Oct 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验